Listed

Petmed Express Inc: Form 10-Q for the period ended Sep 30, 2020

Filed with the SEC on Nov 3, 2020 and accepted by EDGAR at Nov 3, 2020, 15:22 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-07-01 to 2020-09-30$75.4mus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
Revenue6 months2020-04-01 to 2020-09-30$171.6mus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
Cost of revenue3 months2020-07-01 to 2020-09-30$52.4mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2020-04-01 to 2020-09-30$121.8mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2020-07-01 to 2020-09-30$23.0mus-gaap:GrossProfit
Gross profit6 months2020-04-01 to 2020-09-30$49.8mus-gaap:GrossProfit
Operating income3 months2020-07-01 to 2020-09-30$10.5mus-gaap:OperatingIncomeLoss
Operating income6 months2020-04-01 to 2020-09-30$19.9mus-gaap:OperatingIncomeLoss
Income tax3 months2020-07-01 to 2020-09-30$2.5mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2020-04-01 to 2020-09-30$4.5mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2020-07-01 to 2020-09-30$8.4mus-gaap:NetIncomeLoss
Net income6 months2020-04-01 to 2020-09-30$16.2mus-gaap:NetIncomeLoss
Diluted EPS3 months2020-07-01 to 2020-09-30$0.42us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2020-04-01 to 2020-09-30$0.81us-gaap:EarningsPerShareDiluted
Basic EPS3 months2020-07-01 to 2020-09-30$0.42us-gaap:EarningsPerShareBasic
Basic EPS6 months2020-04-01 to 2020-09-30$0.81us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2020-07-01 to 2020-09-3020,154,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2020-04-01 to 2020-09-3020,098,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2020-04-01 to 2020-09-30$15.2mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2020-04-01 to 2020-09-30$1.2mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2020-04-01 to 2020-09-30$11.4mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases6 months2020-04-01 to 2020-09-30$0us-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2020-09-30$106.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-09-30$132.6mus-gaap:AssetsCurrent
Total assetsAt period end2020-09-30$158.9mus-gaap:Assets
Current liabilitiesAt period end2020-09-30$21.2mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-09-30$22.5mus-gaap:Liabilities
Shareholders' equityAt period end2020-09-30$136.4mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001437749-20-022358. Last ingested by Listed: Nov 13, 2026, 14:26 ET. Listed shows no prices and gives no investment advice.